Finacea® (azelaic acid) Foam, 15% is indicated for topical treatment of the inflammatory papules and pustules of mild to moderate rosacea.
The first and only prescription foam approved by the FDA for the treatment of rosacea
In the art of rosacea therapy
Proven efficacy has another profile with Finacea® Foam
A hydrophilic foam that is
light and airy
50 g aluminum can
- Finacea® Foam is azelaic acid suspended in an oil-in-water emulsion vehicle
- Contains 2 emollients — Cetostearyl alcohol —Medium-chain triglycerides, diglycerides, monoglycerides
- Contains a humectant — Propylene glycol
- Not alcohol-based
- Manufactured in Switzerland for Bayer HealthCare Pharmaceuticals Inc.
Reference: Finacea® (azelaic acid) Foam, 15% [package insert]. Whippany, NJ: Bayer HealthCare Pharmaceuticals Inc; 2015.